PCM
BDSX icon

Perkins Capital Management’s Biodesix BDSX Stock Holding History

Perkins Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$649K Hold
44,783
– – 0.61% 48
2025
Q4 		$305K Sell
44,783
-7,850
-15% -$57.8K 0.24% 71
2025
Q3 		$397K Sell
52,633
-353
-0.7% -$2.71K 0.35% 58
2025
Q2 		$299K Hold
52,986
– – 0.3% 61
2025
Q1 		$663K Sell
52,986
-25
-0% -$480 0.7% 46
2024
Q4 		$1.62M Buy
53,011
+16,772
+46% +$493K 1.44% 23
2024
Q3 		$1.29M Buy
36,239
+15,500
+75% +$533K 1.21% 27
2024
Q2 		$635K Buy
+20,739
New +$592K 0.6% 52

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Perkins Capital Management's BDSX Position: Q1 2026 in Review

Perkins Capital Management held its Biodesix (BDSX) position steady in Q1 2026 at 44,783 shares worth $649K. The position accounts for 0.61% of the portfolio, ranked #48.

Perkins Capital Management first reported a position in BDSX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.62M in Q4 2024. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Perkins Capital Management held 44,783 shares of Biodesix worth $649K as of Q1 2026.
  • Perkins Capital Management left its Biodesix share count unchanged in Q1 2026.
  • Biodesix made up 0.61% of Perkins Capital Management's portfolio in Q1 2026, its #48 holding.
  • Perkins Capital Management first reported a position in Biodesix in Q2 2024 and has held it in 8 quarters since.
  • Perkins Capital Management's Biodesix position peaked at $1.62M in Q4 2024.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Perkins Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.